Posted in | News | Mining Business

Global Mining Production Growth to Support METS Sector Recovery, says GlobalData

Global ROM (Run of Mine) production, from over 100 mineral commodities and 150 countries, reached 18.5 billion tonnes in 2017. By 2022, this figure is expected to reach 20.5 billion tonnes, an increase of 3.1% per year, according to GlobalData, a leading data and analytics company.

Ankita Awasthi, Senior Mining Analyst at GlobalData, comments: “This growth signals more encouraging times for the mining equipment, technology and services (METS) sector with growth in mining aftermarket sales in particular linked to growth in ROM production.”

Through to 2022, iron ore mine ROM production is forecast to grow at a Compound Annual Growth Rate (CAGR) of 5.9%, while coal will decline, albeit by a marginal 0.4%. Among the other commodities, gold and copper will grow by 8.6% and 5.9% per year respectively.

Asia-Pacific is the largest contributor to the global ROM production, accounting for 23.7% in 2017, followed by South and Central America (18.8%) and North America (16.8%), with the top ten countries being Australia, United States, China, India, Russia, Brazil, Chile, Canada, South Africa, and Peru.

Awasthi continues: “These markets collectively accounted for over 70% of the global total. Highest growth is expected in Oceania at 5.5% per year, followed by the Middle East & Africa, whilst mine closures in Europe are expected to lead to an annual decline of 4.1% in the region through to 2022.”

Vale, Rio Tinto, Coal India, BHP, Freeport, Glencore, China Shenhua Energy, Codelco, Barrick and Anglo American were the top ten companies in 2017 jointly accounting for approximately 25% of the global share.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.